Jesse Joel Thathapudi

Dr. Jesse Joel Thathapudi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2022 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
NBNagaraj Basavegowda
Nagaraj Basavegowda
Prathap SomuPrathap Somu
Prathap Somu
ASAsma Musfira Shabbirahmed
Asma Musfira Shabbirahmed
LGLevin Anbu Gomez
Levin Anbu Gomez
JTJesse Joel Thathapudi
Jesse Joel Thathapudi

28 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Rajkumar SekarRajkumar Sekar
Rajkumar Sekar
Nagaraj BasavegowdaNagaraj Basavegowda
Nagaraj Basavegowda
JTJesse Joel Thathapudi
Jesse Joel Thathapudi
MSMedidi Raja Sekhar
Medidi Raja Sekhar
PJParinita Joshi
Parinita Joshi
Kwang-Hyun BaekKwang-Hyun Baek
Kwang-Hyun Baek
Cancer is one of the most dangerous health problems in the millennium and it is the third foremost human cause of death in the universe. Traditional cancer treatments face several disadvantages and cannot often afford adequate outcomes. It has been exhibited that the outcome of several therapies can be improved when associated with nanostructures. In addition, a modern tendency is being developed in cancer therapy to convert single-modal into multi-modal therapies with the help of existing various nanostructures. Among them, gold is the most successful nanostructure for biomedical applications due to its flexibility in preparation, stabilization, surface modifications, less cytotoxicity, and ease of bio-detection. In the past few decades, gold-based nanomaterials rule cancer treatment applications, currently, gold nanostructures were the leading nanomaterials for synergetic cancer therapies. In this review article, the synthesis, stabilization, and optical properties of gold nanostructures have been discussed. Then, the surface modifications and targeting mechanisms of gold nanomaterials will be described. Recent signs of progress in the application of gold nanomaterials for synergetic cancer therapies such as photodynamic and photo-thermal therapies in combination with other common interventions such as radiotherapy, chemotherapy, and will be reviewed. Also, a summary of the pharmacokinetics of gold nanostructures will be delivered. Finally, the challenges and outlooks of the gold nanostructures in the clinics for applications in cancer treatments are debated.

20 April 2016 in Asian Journal of Pharmaceutical Research and Health Care
Verified
Journal Article
Open access
PDF file
JTJesse Joel Thathapudi
Jesse Joel Thathapudi
SSS. Suguna
S. Suguna
SSS. R. Steffi
S. R. Steffi
Saliva contains a number of antimicrobial substances which have their origin either in salivary glands or serum from which they may leak into the mouth via the gingival crevices. Saliva is believed to possess a substantial influence on the aggregates oral pathogens form in the mouth due to the antibodies as well as proteins whose antimicrobial properties do not depend on prior exposure to an antigen. One such enzyme is Lysozyme which is one of the most powerful natural antibacterial and antiviral compounds known to man. According to previous researches, it has been found out that lysozyme may bind and aggregate Gram-positive bacteria such as putative Gram-negative periodontopathic bacteria such as Capnocytophaga gingivalis. This particular study explores the natural phenomenon Lysozyme exhibits against oral microflora with noteworthy conclusions. Saliva samples were collected from the oral cavity of human, cow and dog. From these samples, lysozyme was isolated and purified. Furthermore, the quantity of the enzyme isolated was ascertained by Polyacrylamide Gel Electrophoresis. The quantified enzyme showed 32kDa for cow sample, 23kDa for dog sample and 23kDa for human sample. Finally the antimicrobial activity of the enzyme was determined by agar well diffusion method against Staphylococcus spp. and Enterococcus faecalis. Hence lysozyme in saliva is found to have the antibacterial activity against the pathogen due to the zone of inhibition observed and this proves that a tool to prevent dental decay is available and that there is potential to serve antimicrobial role in the specific application of medical industry.

30 September 2019 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
JTJesse Joel Thathapudi
Jesse Joel Thathapudi
JSJagadish Kumar Suluvoy
Jagadish Kumar Suluvoy
JVJency Varghese
Jency Varghese

30 December 2018 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
JTJesse Joel Thathapudi
Jesse Joel Thathapudi
JSJesvin Shobini
Jesvin Shobini

1 December 2021 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
JSJagadish Kumar Suluvoy
Jagadish Kumar Suluvoy
PGP. Levin Anbu Gomez
P. Levin Anbu Gomez
JTJesse Joel Thathapudi
Jesse Joel Thathapudi
NTNeha Toppo
Neha Toppo
DKDhanu P. Karthikeyan
Dhanu P. Karthikeyan
RSRitu Shepherd
Ritu Shepherd